Insulin resistance: A metabolic pathway to chronic liver disease
By E. Bugianesi, A. McCullough, Giulio Marchesini. Hepatology, 2005
920 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Surgery
View Paper: https://www.semanticscholar.org/paper/2befa27c6aa8b54b501f759e5212a306219ea924
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- Ewout W. Steyerberg
- Gang Luo
- Karel G. M. Moons
- Gary S. Collins
- Johannes B Reitsma
- Peter C. Austin
- Douglas G. Altman
- P. Mohapatra
In Epidemiology
In Surgery
- Ewout W. Steyerberg
- Gang Luo
- Karel G. M. Moons
- Gary S. Collins
- Johannes B Reitsma
- Peter C. Austin
- Douglas G. Altman
- P. Mohapatra
Citations in the corpus
- Role of Kupffer cells in host defense and liver disease (2006, background): “In line with these observations a recent study reported a high frequency of small intestinal bacterial over- growth in patients with NASH (123) suggesting that gut-derived portal endotoxin may be an important stimulus for KC activation in NAFLD.”
- A position statement on NAFLD/NASH based on the EASL 2009 special conference. (2010, methodology): “Other methods are based on fasting values, mainly indicative of hepatic sensitivity, or on the dynamics of glucose and insulin in response to an oral glucose tolerance test [130,131], indicative of hepatic and peripheral insulin sensitivity.”
- The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population (2006, background): “Hyperinsulinemia and insulin resistance are common in subjects with FL independently from BMI and thus are expected to be markers of FL in the general population [12].”